Safe pneumonectomy for locally advanced lung cancer after induction therapy

被引:0
作者
Tetsuhiko Go
Toshihiro Ikeda
Naoya Yokota
Atsushi Fujiwara
Yasuhiro Otsuki
Ayumu Kato
Sung Soo Chang
Noriyuki Misaki
Dage Liu
Hiroyasu Yokomise
机构
[1] Kagawa University,Department of General Thoracic, Breast and Endocrinological Surgery, Faculty of Medicine
来源
Surgery Today | 2022年 / 52卷
关键词
Induction therapy; Pneumonectomy; Advanced lung cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:316 / 323
页数:7
相关论文
共 121 条
[1]  
Weder W(2010)Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non–small-cell lung cancer J Thorac Cardiovasc Surg 139 1424-1430
[2]  
Collaud S(2008)Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy Ann Thorac Surg 86 376-382
[3]  
Eberhardt WE(2016)Pneumonectomy for clinical stage IIIA non-small cell lung cancer: the impact of neoadjuvant therapy Ann Thorac Surg 101 451-458
[4]  
Hillinger S(2009)Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 379-386
[5]  
Welter S(2019)Pneumonectomy in stage IIIA-N2 NSCLC: should it be considered after neoadjuvant chemotherapy? Clin Lung Cancer 20 97-106
[6]  
Stahel R(2017)Pneumonectomy is safe and effective for non-small cell lung cancer following induction therapy J Thorac Dis 9 4447-4453
[7]  
Gudbjartsson T(2013)Pneumonectomy with and without induction chemo-radiotherapy for non-small cell lung cancer: short and long-term results from a single centre Eur Rev Med Pharmacol Sci 17 29-40
[8]  
Gyllstedt E(2007)Induction chemoradiotherapy (Carboplatin-Taxane and Concurrent 50-Gy Radiation) for bulky cN2, N3 non-small cell lung cancer J Thorac Cardiovasc Surg 133 1179-1185
[9]  
Pikwer A(2009)New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 228-247
[10]  
Jönsson P(2006)Correlation of FDG-PET findings with histopathology in the assessment of response to induction chemoradiotherapy in non-small cell lung cancer Eur J Nucl Med Mol Imaging 33 140-147